Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,026–5,050 of 7,816 matching trials · page 202 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Multidisciplinary Intervention Including a Clinical Decision Support System and an App for Drug Therapy Management in Older Patients NCT04391218 Multidisciplinary Approach Group |
NA other |
UNKNOWN | 89 | A.O.U. Città della Salute e della Scienza OTHER |
2021-03-05 |
|
Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment NCT02982642 1612 capsule; Placebos Runs in: China · 1 site |
PHASE4 other |
WITHDRAWN | 0 | Dongzhimen Hospital, Beijing OTHER |
2021-03-04 |
|
South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention NCT03980392 Multidomain intervention program Runs in: South Korea · 6 sites |
NA other |
COMPLETED | 152 | Inha University Hospital OTHER |
2021-03-04 |
|
A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation NCT00723606 Intramuscular ziprasidone mesylate; Intramuscular haloperidol Runs in: China · 9 sites |
PHASE3 other |
COMPLETED | 376 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. INDUSTRY |
2021-03-03 |
|
Neurofeedback in Alzheimer's Disease NCT03790774 Neurofeedback Runs in: United States · 1 site |
NA other |
TERMINATED | 5 | Oregon Health and Science University OTHER |
2021-03-03 |
|
The Therapeutic Effects of Equine-Assisted Psychotherapy NCT04200612 Equine-Assisted Psychotherapy; Equine-Assisted Activities; Placebo-... Runs in: Singapore · 1 site |
NA other |
COMPLETED | 102 | Chua Yi Rong Shawn OTHER |
2021-03-03 |
|
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach NCT02614365 Aerobic exercise; Stretch exercise Runs in: United States · 1 site |
NA other |
UNKNOWN | 80 | Howard University OTHER |
2021-03-02 |
|
Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia NCT03230071 TMBCZG; placebo Runs in: China · 1 site |
PHASE2 other |
COMPLETED | 160 | Dongzhimen Hospital, Beijing OTHER |
2021-03-02 |
|
Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials NCT03543878 Flicker Runs in: United States · 1 site |
NA other |
COMPLETED | 10 | Emory University OTHER |
2021-03-02 |
|
The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment NCT02180529 Methylphenidate; Placebo Runs in: Israel · 1 site |
NA other |
TERMINATED | 16 | Meir Medical Center OTHER |
2021-02-25 |
|
Transcranial Magnetic Stimulation in Mild Cognitive Impairment and Alzheimer Disease NCT04771845 Transcranial Magnetic Stimulation |
NA other |
COMPLETED | 73 | The New York Memory Services OTHER |
2021-02-25 |
|
The Effect of rTMS Treatment on Alzheimer's and Sleep Quality NCT01894620 rTMS real-sham; rTMS sham-real Runs in: Canada · 2 sites |
NA other |
COMPLETED | 11 | Dr. Zahra Kazem-Moussavi OTHER |
2021-02-24 |
|
Orexin and Tau Pathology in Cognitively Normal Elderly NCT03053908 Actigraphy; Nocturnal Polysomnograpahy (NPSG) Runs in: United States · 1 site |
NA other |
COMPLETED | 25 | NYU Langone Health OTHER |
2021-02-24 |
|
Brain Fitness APP for Cognitive Enhancement NCT03587012 Brain fitness app; Brain fitness app with tACS Runs in: Canada · 1 site |
NA other |
UNKNOWN | 30 | University of Manitoba OTHER |
2021-02-24 |
|
Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke NCT03815292 MMH-MAP; Placebo Runs in: Russia · 28 sites |
PHASE3 other |
COMPLETED | 276 | Materia Medica Holding INDUSTRY |
2021-02-23 |
|
Exploring Use of Companion Robot Pets for Older Adults in Care Homes NCT04168463 Two Joy for All robots (one cat and one dog) Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 83 | University of Plymouth OTHER |
2021-02-23 |
|
CAndesartan vs LIsinopril Effects on the BRain NCT01984164 Candesartan; Lisinopril Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 176 | Emory University OTHER |
2021-02-21 |
|
Effects of Group Music Therapy Interventions on Alzheimer's Disease Patients: a Three-arm Randomized Controlled Blind Study. NCT04761497 Actice music therapy; Watching nature videos; Passive music therapy Runs in: Spain · 1 site |
NA other |
COMPLETED | 90 | Universidad Católica San Antonio de Murcia OTHER |
2021-02-21 |
|
To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients. NCT00151502 Atorvastatin Runs in: Australia; Austria; Canada; Denmark; Germany; South Afric... · 99 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 600 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. INDUSTRY |
2021-02-18 |
|
Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome NCT02957123 Intranasal auto-M2-BFs Runs in: Russia · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 30 | Russian Academy of Medical Sciences OTHER |
2021-02-18 |
|
Cholinergic Markers Alzheimer's Disease NCT03090854 ADASCog Runs in: France · 1 site |
NA other |
COMPLETED | 100 | Assistance Publique - Hôpitaux de Paris OTHER |
2021-02-18 |
|
Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis NCT04760171 |
NA other |
UNKNOWN | 10 | The Leeds Teaching Hospitals NHS Trust OTHER |
2021-02-18 |
|
Aricept to Improve Functional Tasks in Vascular Dementia NCT00457769 Donepezil and self-generated memory training; Donepezil and experim... Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
UNKNOWN | 18 | Kessler Foundation OTHER |
2021-02-17 |
|
Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia NCT04095962 Exercise Runs in: Portugal · 1 site |
NA other |
UNKNOWN | 110 | Universidade do Porto OTHER |
2021-02-17 |
|
Feasibility - Infinitome NCT04563767 Infinitome Runs in: United States · 1 site |
NA other |
COMPLETED | 4 | HealthPartners Institute OTHER |
2021-02-17 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial